Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 10, 2025 08:30 ET | Source: Moleculin Biotech, Inc.

Moleculin Announces Exercise of Warrants for $6.8 Million Gross Proceeds

HOUSTON, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates...
December 02, 2025 10:33 ET | Source: Research and Markets

Me Too Drugs Industry Research Report 2025: Market to Reach $541.86 Million by 2030, Driven by Lower R&D Risk, Therapeutic Alternatives, and Opportunities from Patent Expirations

Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The "Me Too Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ResearchAndMarkets.com's...
November 26, 2025 09:00 ET | Source: Moleculin Biotech, Inc.

Moleculin Announces Reverse Stock Split

HOUSTON, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that it filed an amendment to its amended and restated certificate...
November 17, 2025 09:33 ET | Source: Research and Markets

$9.85 Bn Pharma And Biotech CRM Software Global Market Opportunities And Strategies To 2034: Top 10 Players Control 94.96% of 2023 Market, Led by Veeva Systems at 26.81% Share

Dublin, Nov. 17, 2025 (GLOBE NEWSWIRE) -- The "Pharma And Biotech CRM Software Global Market Opportunities And Strategies To 2034" report has been added to ResearchAndMarkets.com's offering. This...
November 13, 2025 08:36 ET | Source: Moleculin Biotech, Inc.

Moleculin Reports 60% of First 45 Subjects in Pivotal “MIRACLE” Phase 3 AML Trial Consented

Completion of treatment for the first 45 patients on pace for Q1 2026 with initial unblinded data thereafter; blinded response activity tracking within expected range HOUSTON, Nov. 13, 2025 (GLOBE...
November 11, 2025 10:43 ET | Source: Research and Markets

Rozanolixizumab (Rystiggo) Market Research 2025: Rising Prevalence of Autoimmune and Neurological Disorders, Which Demand Targeted and Effective Therapeutic Options Fueling Expansion

Dublin, Nov. 11, 2025 (GLOBE NEWSWIRE) -- The "Rozanolixizumab (Rystiggo) Market - Global Industry Size, Share, Trends, Opportunity & Forecast, 2020-2030F" report has been added to ...
November 10, 2025 11:58 ET | Source: Research and Markets

U.S. $882.63 Bn Pharmaceutical Market Trends, Competition, Opportunities & Forecasts, 2030F - Companies Focused on Value-driven, Patient-centric Strategies Will Thrive Despite Pricing Pressures

Dublin, Nov. 10, 2025 (GLOBE NEWSWIRE) -- The "U.S. Pharmaceutical Market, By Region, By Competition, Opportunities & Forecast, 2020-2030F" report has been added to ResearchAndMarkets.com's...
November 05, 2025 09:50 ET | Source: Research and Markets

EU and UK Competition Law for the Pharmaceutical Industry Online Training Course: Uses Case Studies and Real-world Examples to Address How Compliance Works in Practice (Feb 27, 2026)

Dublin, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The "Competition Law for the Pharmaceutical Industry Training Course (Feb 27, 2026)" training has been added to ResearchAndMarkets.com's offering. This...
November 04, 2025 10:20 ET | Source: Research and Markets

Pharma 5.0 Research Report 2025: Market to Reach $98.7 Billion by 2029 as AI, Big Data, and Precision Medicine Accelerate Next-Gen Pharma Transformation - Global Long-term Forecast to 2034

Dublin, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The "Pharma 5.0 Market Report 2025" report has been added to ResearchAndMarkets.com's offering.The pharma 5 market size has grown strongly in recent years....
October 30, 2025 06:45 ET | Source: Research and Markets

Canada Pharmaceutical Market Report 2025: A $48.11 Billion Industry by 2033, Driven by Aging Populations, Rising Chronic Disease Prevalence, Supportive Regulations, and Strong R&D Infrastructure

Dublin, Oct. 30, 2025 (GLOBE NEWSWIRE) -- The "Canada Pharmaceutical Market Report by ATC / Therapeutic Class, Drug Type, Distribution Channel, Region, and Company Analysis, 2025-2033" report has...